Physician profile
Daniel Patrick Pap
NPI 1306136429
$2,149.73
in general payments reported to CMS, 2019-2025
17 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $361 · 2020: $215 · 2021: $398 · 2022: $478 · 2023: $311 · 2024: $242 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $697.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $697.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $310.07 | 2021-2022 | |
| Impel Pharmaceuticals INC. | $225.99 | 2022-2023 | Trudhesa |
| Medtronic, INC. | $221.80 | 2021-2023 | Aquamantys(Tm) |
| Boston Scientific Corporation | $216.82 | 2019-2024 | |
| Pfizer INC. | $174.68 | 2019-2020 | |
| Stryker Corporation | $160.07 | 2022-2025 | Optablate |
| Cdc Medical LLC | $156.08 | 2023 | |
| Abbott Laboratories | $144.03 | 2019-2024 | Eterna |
| Si-Bone, INC. | $143.16 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $86.91 | 2021 | |
| Medtronic USA, INC. | $83.55 | 2019-2020 | |
| Nalu Medical, INC. | $81.08 | 2022-2023 | Nalu Neurostimulation System |
| Biohaven Pharmaceutical Holding Company Ltd. | $36.74 | 2022 | |
| Eli Lilly and Company | $32.79 | 2022 | |
| Nevro Corp. | $31.11 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $28.50 | 2024 | Iovera, Zilretta, Exparel |
| Bioventus LLC | $16.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Pap listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.